{
    "2020-05-19": [
        [
            {
                "time": "",
                "original_text": "营收增速放缓 CRO巨头泰格医药赴港上市出海找路 盈利能力下降",
                "features": {
                    "keywords": [
                        "营收增速",
                        "CRO",
                        "泰格医药",
                        "赴港上市",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-19",
                "original_text": "粤开策略资金面 | 双重利好提振市场情绪，科技股表现强势-0519",
                "features": {
                    "keywords": [
                        "粤开策略",
                        "双重利好",
                        "市场情绪",
                        "科技股",
                        "表现强势"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：医药指数创近五年来新高",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业日报",
                        "医药指数",
                        "新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：持股5%以上股东870万股公司股份解除质押",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "持股5%",
                        "股东",
                        "解除质押",
                        "870万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：持股5%以上股东曹晓春解押870万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "持股5%",
                        "曹晓春",
                        "解押",
                        "870万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：医药高位震荡格局延续",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业日报",
                        "高位震荡",
                        "格局延续"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【华西医药崔文亮团队】《医药生物行业点评报告：两会医药议题解读：疫苗、创新药、IVD和医疗设备等领域继续成为关注焦点》",
                "features": {
                    "keywords": [
                        "华西医药",
                        "崔文亮团队",
                        "两会医药议题",
                        "疫苗",
                        "创新药",
                        "IVD",
                        "医疗设备",
                        "关注焦点"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}